Search
Home > Our Company > News > Press Release > CooperVision Introduces MyDay Energys®: Innovative Next-Generation Sphere Technology Designed for Exceptional Comfort 1,2

CooperVision Introduces MyDay Energys®: Innovative Next-Generation Sphere Technology Designed for Exceptional Comfort 1,2

September 21, 2026

 New premium daily disposable contact lens3 combines innovative optical design and Aquaform® Technology4-6 to support comfortable lens wear3 throughout today's demanding lifestyles.7

 

ROCHESTER, N.Y., 21st September 2026 – CooperVision®, a global leader in contact lenses,*8 today announced the rollout of MyDay Energys® across United Kingdom & Ireland, introducing its most comfortable one-day contact lens ever.1,2 Designed to meet the needs of today's visually demanding lifestyles,7 the premium daily disposable3 lens combines innovative optical design with material science4 to help deliver outstanding comfort throughout the day.3

 

As people spend increasing amounts of time looking at digital screens throughout the day,9 comfort has become one of the most important factors influencing contact lens satisfaction.†10While contact lens comfort is often associated with lens materials alone, research suggests that visual demands can also play an important role in the overall wearing experience.11

 

MyDay Energys® has been developed with this broader view of comfort in mind. The lens combines CooperVision's ComfortBoost® technology with Aquaform® Technology,4-6 working together to support comfortable, relaxed eyes throughout the day.‡12

 

ComfortBoost® technology helps eyes maintain focus with less effort during everyday visual tasks, supporting visual comfort throughout the day.§◊1,13Aquaform® Technology retains water within the lens material, providing natural wettability and helping deliver incredible all-day comfort.3

 

Clinical studies demonstrate strong wearer preference for the lens.‡1,12 Patients rated end-of-day comfort higher with MyDay Energys® compared with MyDay®,1 while twice as many patients preferred MyDay Energys® for eyes feeling less dry at the end of the day.1 Wearers also reported comfortable, relaxed eyes throughout the day despite frequently viewing digital devices.‡12

 

By addressing both visual demands and material comfort,§1,4 MyDay Energys® offers a more comprehensive approach to contact lens comfort for today's patients.

 

"Comfort remains one of the most important drivers of contact lens satisfaction, and expectations continue to evolve as patients spend more time engaging with screens at work, at home and on the move," said Lucy Davies, Director of Marketing & Professional Affairs UK & Ireland "MyDay Energys® builds on the trusted performance of the MyDay® family and introduces a new approach to comfort that considers both lens material and visual demands. We're excited to bring this latest innovation to eye care professionals across United Kingdom & Ireland."

 

MyDay Energys® joins CooperVision's established MyDay® portfolio, which includes spherical, toric, multifocal and myopia control options, helping eye care professionals meet the needs of a broad range of patients with a comprehensive daily disposable platform.14

 

MyDay Energys® is now available in United Kingdom & Ireland.

 

For more information, visit coopervision.co.uk/energys.

 

###

About CooperVision

CooperVision, a division of CooperCompanies (Nasdaq: COO), is a global leader in contact lens innovation, dedicated to advancing vision at every stage of life. The company offers one of the industry’s most comprehensive portfolios of soft and specialty contact lenses—including daily disposable, two-week and monthly options—with high performance materials and optics across spherical, toric, and multifocal designs. With a strong heritage of addressing complex vision challenges such as childhood myopia, astigmatism, presbyopia, and irregular corneas, CooperVision combines purposeful research and development, state of the art manufacturing, and deep practitioner partnerships to deliver clinically advanced solutions. Decades of experience and insight continue to shape the eye care profession and create meaningful advantages for both practitioners and wearers. For more information, visit www.coopervision.com

 

About CooperCompanies

CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, Calif., CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com. 

Media Contact

Naomi Snuggs

Just Communications
naomi@justcommunications.co.uk 
07733 233647

 

 

 

 

 

More News Articles

Footnotes

*Combination of 2022 market research based on global volume data and internal estimates.

†19.1% of points where respondents were asked to divide 100 points over a number of aspects.

‡23% strongly agreed, 31% agreed, 21% slightly agreed.

§Compared to MyDay® sphere.

◊Based on a statistically significant difference of the mean change in Accommodative Microfluctuations and when compared to a lens without ComfortBoost® after reading on an iPhone 5 for 20 minutes held at a distance of 25 cm. Study conducted with Biofinity Energys® and sphere.

 

 

References

1. CVI data on file, 2018. Prospective, multi-centre (5 US sites), open label, bilateral wear, one-week dispensing study with MyDay® and MyDay Energys®. N=77 habitual soft CL wearers.

2. CVI data on file, 2024 & 2026.

3. CVI data on file, 2026.

4. CVI data on file, 2024.

5.  CVI data on file, 2016; bilateral, double masked, multi-centre, cross over study with Biofinity and Biofinity Energys. N=44 habitual soft contact lens wearers.

6. Montani G et al. Effects of different contact lens design on accommodative function and eyestrain symptoms of young adult subjects after VDT use. BCLA 2021 conference presentation.

7. CVI data on file, 2023. US in market assessment survey conducted by 23 ECPs:  n=207 habitual contact lens patients refit into MyDay Energys® contact lenses after one week of daily wear. ECP's Top 2 Box: 100%.

8. CVI data on file, 2023.

9. Kumar, N. Average Screen Time Statistics 2026 (By Age & Country) Average Screen Time Statistics 2026 [By Age & Country] Accessed 15th April 2026.

10. CVI data on file, 2024, Consumer segmentation online survey, Decision Analyst, August 2024. Contact lens wearers, n= 3725 (n=1200 US, n=499 UK, n=503 Germany, n=500 Japan, n=350 South Korea, n= 248 Poland, n=425 Italy).

11. Rueff EM. Visual discomfort and contact lens wear: A review. Contact Lens and Anterior Eye. 2023;46(4):101872.

12. CVI data on file, 2018. Prospective, multi-centre (5 US sites), open label, bilateral wear, one week dispensing study with MyDay Energys®. N=77 habitual soft CL wearers.

13. Kajita M et al. Changes in accommodative micro-fluctuations after wearing contact lenses of different optical designs. CLAE 2020; 43(5): 493-496.

14. CVI data on file 2022; Rx coverage database n=203,946 eyes; 14 to 41 years for MyDay® sphere and MyDay® toric and MyDay Energys®; 42 to 70 years for MyDay® multifocal.

CVM10262041-1